Phosphorylation of phospholamban promotes SERCA2a activation by dwarf open reading frame (DWORF)

被引:0
|
作者
Bovo, Elisa [1 ]
Jamrozik, Thomas [1 ]
Kahn, Daniel [1 ]
Karkut, Patryk [1 ]
Robia, Seth L. [1 ]
Zima, Aleksey, V [1 ]
机构
[1] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, 2160 South First Ave, Maywood, IL 60153 USA
关键词
Ca pump; DWORF; Phospholamban; Ca signaling; HEK293; cells; OLIGOMERIZATION; CONTRACTION; REGULATOR; MUTATION; ALTER; SITE; CA2+;
D O I
10.1016/j.ceca.2024.102910
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In cardiac myocytes, the type 2a sarco/endoplasmic reticulum CaATPase (SERCA2a) plays a key role in intracellular Ca regulation. Due to its critical role in heart function, SERCA2a activity is tightly regulated by different mechanisms, including micropeptides. While phospholamban (PLB) is a well-known SERCA2a inhibitor, dwarf open reading frame (DWORF) is a recently identified SERCA2a activator. Since PLB phosphorylation is the most recognized mechanism of SERCA2a activation during adrenergic stress, we studied whether PLB phosphorylation also affects SERCA2a regulation by DWORF. By using confocal Ca imaging in a HEK293 expressing cell system, we analyzed the effect of the co -expression of PLB and DWORF using a bicistronic construct on SERCA2amediated Ca uptake. Under these conditions of matched expression of PLB and DWORF, we found that SERCA2a inhibition by non-phosphorylated PLB prevails over DWORF activating effect. However, when PLB is phosphorylated at PKA and CaMKII sites, not only PLB 's inhibitory effect was relieved, but SERCA2a was effectively activated by DWORF. Fo <spacing diaeresis>rster resonance energy transfer (FRET) analysis between SERCA2a and DWORF showed that DWORF has a higher relative affinity for SERCA2a when PLB is phosphorylated. Thus, SERCA2a regulation by DWORF responds to the PLB phosphorylation status, suggesting that DWORF might contribute to SERCA2a activation during conditions of adrenergic stress.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] HNO Enhances SERCA2a Activity and Cardiomyocyte Function by Promoting Redox-Dependent Phospholamban Oligomerization
    Sivakumaran, Vidhya
    Stanley, Brian A.
    Tocchetti, Carlo G.
    Ballin, Jeff D.
    Caceres, Viviane
    Zhou, Lufang
    Keceli, Gizem
    Rainer, Peter P.
    Lee, Dong I.
    Huke, Sabine
    Ziolo, Mark T.
    Kranias, Evangelia G.
    Toscano, John P.
    Wilson, Gerald M.
    O'Rourke, Brian
    Kass, David A.
    Mahaney, James E.
    Paolocci, Nazareno
    ANTIOXIDANTS & REDOX SIGNALING, 2013, 19 (11) : 1185 - 1197
  • [42] Binding site for residue 30 of phospholamban (PLB) on cardiac Ca pump (SERCA2a) localized.
    Jones, LR
    Cornea, RL
    Chen, ZH
    BIOPHYSICAL JOURNAL, 2002, 82 (01) : 265A - 265A
  • [43] α-Kinase Anchoring Protein αKAP Interacts with SERCA2A to Spatially Position Ca2+/Calmodulin-dependent Protein Kinase II and Modulate Phospholamban Phosphorylation
    Singh, Puneet
    Salih, Maysoon
    Tuana, Balwant S.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (41) : 28212 - 28221
  • [44] Up-regulation of phospholamban protects the heart against the replacement of SERCA2a by the higher-Ca2+ affinity SERCA2b isoform
    Vangheluwe, P
    Tjwa, M
    Van den Bergh, A
    Louch, WE
    Herijgers, P
    Kranias, E
    Sipido, K
    Raeymaekers, L
    Wuytack, F
    JOURNAL OF GENERAL PHYSIOLOGY, 2005, 126 (01): : 56A - 56A
  • [45] Fluorescence Spectroscopy Reveals a 2:1 Stoichiometry for Dimeric Cardiac Calcium Pump (SERCA2a) Bound to a Phospholamban Monomer
    Blackwell, Daniel
    Robia, Seth
    FASEB JOURNAL, 2016, 30
  • [46] HNO Enhances SERCA2a Activity and Cardiomyocyte Function by Altering Key Cysteine Residues 41 and 46 in Phospholamban
    Sivakumaran, Vidhya
    Tocchetti, Carlo G.
    Thorpe, Chevon N.
    Ballin, Jeff D.
    Zhou, Lufang
    Lee, Dong I.
    O'Rourke, Brian
    Kass, David A.
    Wilson, Gerald M.
    Mahaney, James E.
    Paolocci, Nazareno
    CIRCULATION, 2011, 124 (21)
  • [47] Phospholamban domain I cytochrome b5 transmembrane sequence chimeras do not inhibit SERCA2a
    Kimura, Y
    Asahi, M
    Kurzydlowski, K
    Tada, M
    MacLennan, DH
    FEBS LETTERS, 1998, 425 (03) : 509 - 512
  • [48] Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure
    Changwon Kho
    Ahyoung Lee
    Dongtak Jeong
    Jae Gyun Oh
    Przemek A. Gorski
    Kenneth Fish
    Roberto Sanchez
    Robert J. DeVita
    Geir Christensen
    Russell Dahl
    Roger J. Hajjar
    Nature Communications, 6
  • [49] Cardiac Beta-arrestin2 Promotes Contractility by Enhancing SERCA2a SUMOylation and Activity
    Lymperopoulos, Anastasios
    Jafferjee, Malika
    Valero, Thairy Reyes
    Marrero, Christine
    McCrink, Katie A.
    Brill, Ava
    Gao, Erhe
    Koch, Walter J.
    CIRCULATION RESEARCH, 2015, 117
  • [50] Cardiac Beta-arrestin2 Promotes Contractility by Enhancing SERCA2a SUMOylation and Activity
    Lymperopoulos, Anastasios
    Jafferjee, Malika
    McCrink, Katie A.
    Valero, Thairy Reyes
    Marrero, Christine
    Brill, Ava
    Huang, Xupei
    CIRCULATION, 2015, 132